These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36801606)

  • 1. The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.
    Bolhuis K; Bond MJG; Van Amerongen MJ; Komurcu A; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik TM; Hermans JJ; De Jong KP; Kazemier G; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; May AM; Punt CJA; Swijnenburg RJ;
    Eur J Cancer; 2023 Apr; 183():49-59. PubMed ID: 36801606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Bond MJG; Kuiper BI; Bolhuis K; Komurcu A; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik T; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Kazemier G; May AM; Punt CJA; Swijnenburg RJ
    Ann Surg Oncol; 2023 Sep; 30(9):5376-5385. PubMed ID: 37118612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
    Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
    J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
    Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
    Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
    Huiskens J; van Gulik TM; van Lienden KP; Engelbrecht MR; Meijer GA; van Grieken NC; Schriek J; Keijser A; Mol L; Molenaar IQ; Verhoef C; de Jong KP; Dejong KH; Kazemier G; Ruers TM; de Wilt JH; van Tinteren H; Punt CJ
    BMC Cancer; 2015 May; 15():365. PubMed ID: 25943574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
    Shah K; Clary B
    Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
    Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial.
    Bolhuis K; Grosheide L; Wesdorp NJ; Komurcu A; Chapelle T; Dejong CHC; Gerhards MF; Grünhagen DJ; van Gulik TM; Huiskens J; De Jong KP; Kazemier G; Klaase JM; Liem MSL; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Punt CJA; Swijnenburg RJ
    Ann Surg Open; 2021 Sep; 2(3):e081. PubMed ID: 37635815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
    Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
    ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review.
    Bolhuis K; Kos M; van Oijen MGH; Swijnenburg RJ; Punt CJA
    Eur J Cancer; 2020 Dec; 141():225-238. PubMed ID: 33189037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.
    Michiel Zeeuw J; Wesdorp NJ; Ali M; Bakker AJJ; Voigt KR; Starmans MPA; Roor J; Kemna R; van Waesberghe JHTM; van den Bergh JE; Nota IMGC; Moos SI; van Dieren S; van Amerongen MJ; Bond MJG; Chapelle T; van Dam RM; Engelbrecht MRW; Gerhards MF; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Quintus Molenaar I; Patijn GA; Rijken AM; Ruers TM; de Wilt JHW; Verpalen IM; Stoker J; Grunhagen DJ; Swijnenburg RJ; Punt CJA; Huiskens J; Verhoef C; Kazemier G
    Eur J Cancer; 2024 Aug; 207():114185. PubMed ID: 38924855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases.
    Hellingman T; Kuiper BI; Buffart LM; Meijerink MR; Versteeg KS; Swijnenburg RJ; van Delden OM; Haasbeek CJA; de Vries JJJ; van Waesberghe JHTM; Zonderhuis BM; van der Vliet HJ; Kazemier G
    Clin Colorectal Cancer; 2021 Dec; 20(4):e263-e272. PubMed ID: 34462211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
    Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
    HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.
    Schwarz RE; Berlin JD; Lenz HJ; Nordlinger B; Rubbia-Brandt L; Choti MA
    HPB (Oxford); 2013 Feb; 15(2):106-15. PubMed ID: 23297721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
    Popescu I; Alexandrescu S; Croitoru A; Boros M
    Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
    Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.